Ibrutinib and Treanda drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ibrutinib (ibrutinib) and Treanda (bendamustine hydrochloride). Common drug interactions include colitis ischaemic among females and respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Ibrutinib and Treanda. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Ibrutinib?

Ibrutinib has active ingredients of ibrutinib. eHealthMe is studying from 13,529 Ibrutinib users. Check the latest studies of Ibrutinib.

What is Treanda?

Treanda has active ingredients of bendamustine hydrochloride. It is often used in non-hodgkin's lymphoma. eHealthMe is studying from 4,411 Treanda users. Check the latest studies of Treanda.

On Jul, 12, 2026

23 people who take Ibrutinib and Treanda together, and have interactions are studied.

Ibrutinib and Treanda drug interactions.

What are the common drug interactions of Ibrutinib and Treanda, by gender? *:

female:

Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Anaemia (lack of blood)
Cough
Febrile neutropenia (fever with reduced white blood cells)
Gastroenteritis clostridial (inflammation of stomach and intestine clostridial)
Haemoglobin decreased
Hypoaesthesia (reduced sense of touch or sensation)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Nasal dryness (dry nose)
Nasal ulcer (ulcer of nose)

male:

Respiratory failure (inadequate gas exchange by the respiratory system)
Diarrhoea
Drug intolerance (drug sensitivity)
Hyperhidrosis (abnormally increased sweating)
Impaired healing
Septic shock (shock due to blood infection)
Skin papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections)
Splenomegaly (enlargement of spleen)
Thrombocytopenia (decrease of platelets in blood)
White blood cell count decreased

What are the common drug interactions of Ibrutinib and Treanda, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anaemia (lack of blood)
Febrile neutropenia (fever with reduced white blood cells)
Gastroenteritis clostridial (inflammation of stomach and intestine clostridial)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Pancreatitis (inflammation of pancreas)
Thrombocytopenia (decrease of platelets in blood)

50-59:

Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Hypotension (abnormally low blood pressure)
Iridocyclitis (inflammation of the iris and ciliary body of the eye)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

60+:

Respiratory failure (inadequate gas exchange by the respiratory system)
Diarrhoea
Drug intolerance (drug sensitivity)
Hyperhidrosis (abnormally increased sweating)
Impaired healing
Septic shock (shock due to blood infection)
Skin papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections)
Splenomegaly (enlargement of spleen)
Thrombocytopenia (decrease of platelets in blood)
White blood cell count decreased

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 15 people, 65.22%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 8 people, 34.78%
Herpes Virus Infection: 2 people, 8.70%
Diarrhea: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Ibrutinib and Treanda?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously